Opti Capital Management, LP - Q2 2022 holdings

$1.04 Billion is the total value of Opti Capital Management, LP's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
 SUPERNUS PHARMACEUTICALSnote 0.625% 4/0$45,737,000
-1.5%
46,902,0000.0%4.40%
+17.6%
 WORKIVA INCnote 1.125% 8/1$39,531,000
-32.8%
36,338,0000.0%3.80%
-19.8%
 VEECO INSTRS INC DELnote 3.750% 6/0$33,575,000
-24.3%
21,000,0000.0%3.23%
-9.6%
 EVERBRIDGE INCnote 0.125%12/1$31,960,000
-3.9%
36,500,0000.0%3.07%
+14.8%
 NUVASIVE INCnote 1.000% 6/0$17,350,000
-3.3%
17,910,0000.0%1.67%
+15.5%
 NOVA LTDnote 10/1$12,963,000
-16.4%
10,000,0000.0%1.25%
-0.2%
 MODEL N INCnote 2.625% 6/0$12,594,000
-5.5%
12,000,0000.0%1.21%
+13.0%
 HESKA CORPnote 3.750% 9/1$8,879,000
-25.4%
6,616,0000.0%0.85%
-10.9%
 NUTANIX INCnote 1/1$6,877,000
-1.2%
6,992,0000.0%0.66%
+18.0%
 WESTERN DIGITAL CORP.note 1.500% 2/0$2,865,000
-1.3%
3,000,0000.0%0.28%
+17.5%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SUPERNUS PHARMACEUTICALS INC14Q1 20236.9%
NEW RELIC INC14Q1 20237.6%
8X8 INC NEW13Q3 20237.4%
MANDIANT INC12Q1 20229.9%
NUTANIX INC12Q4 20227.3%
OPKO HEALTH INC12Q3 20232.1%
INSIGHT ENTERPRISES INC10Q3 20235.6%
ALTERYX INC10Q3 20234.6%
IONIS PHARMACEUTICALS INC10Q1 20233.6%
MODEL N INC10Q3 20231.7%

View Opti Capital Management, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View Opti Capital Management, LP's complete filings history.

Compare quarters

Export Opti Capital Management, LP's holdings